As of this writing, there one clinical trial worldwide actively recruiting for nasal septal perforation repair. Based in China, the trial assesses the safety and efficacy of collagen membrane combined with human clinical grade umbilical cord mesenchymal stem cells transplanted between septal mucosal leaflets.